BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23909490)

  • 1. Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer in a Chinese population.
    Yang Z; Fang X; Pei X; Li H
    Genet Test Mol Biomarkers; 2013 Sep; 17(9):700-6. PubMed ID: 23909490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in ERCC1 and XPF genes and breast cancer risk.
    Pei XH; Yang Z; Lv XQ; Li HX
    Genet Mol Res; 2014 Mar; 13(1):2259-67. PubMed ID: 24737474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer in a Chinese population.
    Li J; Zuo X; Lv X; Kong F; Xu W; Yang S
    Tumour Biol; 2014 Aug; 35(8):7569-74. PubMed ID: 24793015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of single nucleotide polymorphisms of ERCC1 and XPF with colorectal cancer risk and interaction with tobacco use.
    Hou R; Liu Y; Feng Y; Sun L; Shu Z; Zhao J; Yang S
    Gene; 2014 Sep; 548(1):1-5. PubMed ID: 24861646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and susceptibility of ERCC1/XPF gene polymorphisms in Han and Uygur women with breast cancer in Xinjiang, China.
    Li H; Zhou L; Ma J; Zhu Y; Fan J; Li N; Zheng Y; Sha T; Zhai Z; Ma B; Dai Z
    Cancer Med; 2020 Dec; 9(24):9571-9580. PubMed ID: 33067872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer.
    Chen ZH; Wang L; Luo LP
    Genet Mol Res; 2014 Sep; 13(3):7484-91. PubMed ID: 25222248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between ERCC1 and XPF polymorphisms and risk of colorectal cancer.
    Yang H; Li G; Li WF
    Genet Mol Res; 2015 Jan; 14(1):700-5. PubMed ID: 25730007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Polymorphisms at ERCC1/XPF Genes Confer Neuroblastoma Risk in Chinese Children.
    Zhuo ZJ; Liu W; Zhang J; Zhu J; Zhang R; Tang J; Yang T; Zou Y; He J; Xia H
    EBioMedicine; 2018 Apr; 30():113-119. PubMed ID: 29544698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy.
    Lu ZM; Luo TH; Nie MM; Fang GE; Ma LY; Xue XC; Wei G; Ke CW; Bi JW
    Tumour Biol; 2014 Apr; 35(4):2941-8. PubMed ID: 24318989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of DNA damage by XPF, XPG and ERCC1 gene polymorphisms in pesticide-exposed agricultural workers of Punjab, North-West India.
    Kaur K; Kaur R
    Mutat Res Genet Toxicol Environ Mutagen; 2021; 861-862():503302. PubMed ID: 33551103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in ERCC1 and XPF gene and response to chemotherapy and overall survival of non-small cell lung cancer.
    Shi ZH; Shi GY; Liu LG
    Int J Clin Exp Pathol; 2015; 8(3):3132-7. PubMed ID: 26045829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an eastern Chinese population.
    He J; Xu Y; Qiu LX; Li J; Zhou XY; Sun MH; Wang JC; Yang YJ; Jin L; Wei QY; Wang Y
    PLoS One; 2012; 7(11):e49308. PubMed ID: 23166636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of excision repair cross-complimentary group 1 gene polymorphisms with breast and ovarian cancer susceptibility.
    Yang F; Mu X; Bian C; Zhang H; Yi T; Zhao X; Lin X
    J Cell Biochem; 2019 Sep; 120(9):15635-15647. PubMed ID: 31081240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of common ERCC1 polymorphisms in cisplatin-resistant epithelial ovarian cancer patients: A study in Chinese cohort.
    Bao Y; Yang B; Zhao J; Shen S; Gao J
    Int J Immunogenet; 2020 Oct; 47(5):443-453. PubMed ID: 32173978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of polymorphisms in nucleotide excision repair genes on glioma risk in a Chinese population.
    Wang XF; Liu S; Shao ZK
    Gene; 2013 Oct; 529(2):317-20. PubMed ID: 23911298
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Li B; Shi X; Yuan Y; Peng M; Jin H; Qin D
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29752341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
    Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
    Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population.
    He BS; Xu T; Pan YQ; Wang HJ; Cho WC; Lin K; Sun HL; Gao TY; Wang SK
    Oncotarget; 2016 Dec; 7(51):84872-84882. PubMed ID: 27768589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population.
    Zhao R; Ying MF
    Genet Mol Res; 2016 Mar; 15(1):15017263. PubMed ID: 26985954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of excision repair cross-complementing group 1 genotypes to triple negative breast cancer risk.
    Tsai CW; Chang WS; Shen TC; Su CH; Wang HC; Liu LC; Bau DT
    PLoS One; 2018; 13(8):e0202112. PubMed ID: 30096175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.